Assessing Global, Regional, and National Time Trends and Associated Risk Factors of the Mortality in Ischemic Heart Disease Through Global Burden of Disease 2019 Study: Population-Based Study

Background Ischemic heart disease (IHD) is the leading cause of death among noncommunicable diseases worldwide, but data on current epidemiological patterns and associated risk factors are lacking. Objective This study assessed the global, regional, and national trends in IHD mortality and attributable risks since 1990. Methods Mortality data were obtained from the Global Burden of Disease 2019 Study. We used an age-period-cohort model to calculate longitudinal age curves (expected longitudinal age-specific rate), net drift (overall annual percentage change), and local drift (annual percentage change in each age group) from 15 to >95 years of age and estimate cohort and period effects between 1990 and 2019. Deaths from IHD attributable to each risk factor were estimated on the basis of risk exposure, relative risks, and theoretical minimum risk exposure level. Results IHD is the leading cause of death in noncommunicable disease–related mortality (118.1/598.8, 19.7%). However, the age-standardized mortality rate for IHD decreased by 30.8% (95% CI –34.83% to –27.17%) over the past 30 years, and its net drift ranged from –2.89% (95% CI –3.07% to –2.71%) in high sociodemographic index (SDI) region to –0.24% (95% CI –0.32% to –0.16%) in low-middle–SDI region. The greatest decrease in IHD mortality occurred in the Republic of Korea (high SDI) with net drift –6.06% (95% CI –6.23% to –5.88%), followed by 5 high-SDI nations (Denmark, Norway, Estonia, the Netherlands, and Ireland) and 2 high-middle–SDI nations (Israel and Bahrain) with net drift less than –5.00%. Globally, age groups of >60 years continued to have the largest proportion of IHD-related mortality, with slightly higher mortality in male than female group. For period and birth cohort effects, the trend of rate ratios for IHD mortality declined across successive period groups from 2000 to 2004 and birth cohort groups from 1985 to 2000, with noticeable improvements in high-SDI regions. In low-SDI regions, IHD mortality significantly declined in female group but fluctuated in male group across successive periods; sex differences were greater in those born after 1945 in middle- and low-middle–SDI regions and after 1970 in low-SDI regions. Metabolic risks were the leading cause of mortality from IHD worldwide in 2019. Moreover, smoking, particulate matter pollution, and dietary risks were also important risk factors, increasingly occurring at a younger age. Diets low in whole grains and legumes were prominent dietary risks in both male and female groups, and smoking and high-sodium diet mainly affect male group. Conclusions IHD, a major concern, needs focused health care attention, especially for older male individuals and those in low-SDI regions. Metabolic risks should be prioritized for prevention, and behavioral and environmental risks should attract more attention to decrease IHD mortality.

[1]  J. Manson,et al.  Healthy Eating Patterns and Risk of Total and Cause-Specific Mortality. , 2023, JAMA internal medicine.

[2]  Gregory B. Lim Inclusion of remnant cholesterol improves risk prediction for ischaemic heart disease , 2022, Nature Reviews Cardiology.

[3]  C. Norris,et al.  Sex and gender determinants of vascular disease in the global context. , 2022, The Canadian journal of cardiology.

[4]  Danmei Wei,et al.  Age-Period-Cohort Analysis of Ischemic Heart Disease Morbidity and Mortality in China, 1990-2019. , 2022, Circulation journal : official journal of the Japanese Circulation Society.

[5]  Mark D. Huffman,et al.  Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data , 2022, The Lancet. Global health.

[6]  P. López-Jaramillo,et al.  Variations in risks from smoking between high-income, middle-income, and low-income countries: an analysis of data from 179 000 participants from 63 countries. , 2022, The Lancet. Global health.

[7]  F. Hu,et al.  The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases , 2022, Nature Reviews Endocrinology.

[8]  S. Petersen,et al.  European Society of Cardiology: cardiovascular disease statistics 2021. , 2022, European heart journal.

[9]  Christopher J. L. Murray,et al.  Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study , 2022, EClinicalMedicine.

[10]  Jingjing Cai,et al.  Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease. , 2021, Cell metabolism.

[11]  R. Cookson,et al.  The inverse care law re-examined: a global perspective , 2021, The Lancet.

[12]  M. Naghavi,et al.  Burden of Ischemic Heart Disease in Central Asian Countries, 1990–2017 , 2021, International journal of cardiology. Heart & vasculature.

[13]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[14]  V. Fuster,et al.  Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia , 2020, Journal of the American College of Cardiology.

[15]  S. Yusuf,et al.  Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study , 2020, Diabetes Care.

[16]  Peng Yin,et al.  The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990–2017: an analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet. Planetary health.

[17]  D. Lewis,et al.  COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives , 2020, Nature Reviews Cardiology.

[18]  N. Sattar,et al.  Improving prevention strategies for cardiometabolic disease , 2020, Nature Medicine.

[19]  Andrew Bell Age period cohort analysis: a review of what we should and shouldn’t do , 2020, Annals of human biology.

[20]  Jiang He,et al.  The global epidemiology of hypertension , 2020, Nature Reviews Nephrology.

[21]  F. Liang,et al.  Long-Term Exposure to Fine Particulate Matter and Cardiovascular Disease in China. , 2020, Journal of the American College of Cardiology.

[22]  G. Patton,et al.  Time Trends in Cardiovascular Disease Mortality Across the BRICS , 2020, Circulation.

[23]  A. Go,et al.  Association Between Aging of the US Population and Heart Disease Mortality From 2011 to 2017. , 2019, JAMA cardiology.

[24]  M. Battarbee Figure 6 , 2019 .

[25]  K. Narayan,et al.  Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors , 2019, Current Diabetes Reports.

[26]  Colin Berry,et al.  Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. , 2019, The New England journal of medicine.

[27]  S. Yusuf,et al.  Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. , 2019, The Lancet. Global health.

[28]  D. Mozaffarian,et al.  The obesity transition: stages of the global epidemic. , 2019, The lancet. Diabetes & endocrinology.

[29]  Dan J Stein,et al.  Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, Lancet.

[30]  L. Ferrucci,et al.  Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk. , 2018, Circulation research.

[31]  A. Mokdad,et al.  Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. , 2018, Kidney international.

[32]  M. Kivimäki,et al.  Weekly hours of informal caregiving and paid work, and the risk of cardiovascular disease , 2018, European journal of public health.

[33]  S. Yusuf,et al.  The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study , 2017, The Lancet.

[34]  M. Gulati,et al.  Sex differences in coronary heart disease risk factors: rename it ischaemic heart disease! , 2017, Heart.

[35]  David Card,et al.  Every Breath You Take—Every Dollar You’ll Make: The Long-Term Consequences of the Clean Air Act of 1970 , 2017, Journal of Political Economy.

[36]  K. Narayan,et al.  Obesity in Low- and Middle-Income Countries: Burden, Drivers, and Emerging Challenges. , 2017, Annual review of public health.

[37]  P. Libby,et al.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.

[38]  H. Lee,et al.  Thirty-Year Trends in Mortality from Cerebrovascular Diseases in Korea , 2016, Korean circulation journal.

[39]  G. Galea,et al.  Tobacco control in Europe: a policy review , 2016, European Respiratory Review.

[40]  B. Hanratty,et al.  Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies , 2016, Heart.

[41]  K. Bibbins-Domingo,et al.  Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease. , 2015, Archives of medical research.

[42]  J. Rehm,et al.  Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers , 2014, BMC Medicine.

[43]  P. Rosenberg,et al.  A Web Tool for Age–Period–Cohort Analysis of Cancer Incidence and Mortality Rates , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[44]  Alan D. Lopez,et al.  Measuring the global burden of disease. , 2013, The New England journal of medicine.

[45]  M. Bennett,et al.  Aging and Atherosclerosis: Mechanisms, Functional Consequences, and Potential Therapeutics for Cellular Senescence , 2012, Circulation research.

[46]  P. Rosenberg,et al.  Age-Period-Cohort Models in Cancer Surveillance Research: Ready for Prime Time? , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[47]  Colin Mathers,et al.  The health of aging populations in China and India. , 2008, Health affairs.

[48]  P. Schnohr,et al.  The combined influence of leisure-time physical activity and weekly alcohol intake on fatal ischaemic heart disease and all-cause mortality. , 2007, European heart journal.

[49]  K. Yano,et al.  Caloric Restriction, the Traditional Okinawan Diet, and Healthy Aging , 2007, Annals of the New York Academy of Sciences.

[50]  C. Pope,et al.  Ischemic Heart Disease Events Triggered by Short-Term Exposure to Fine Particulate Air Pollution , 2006, Circulation.

[51]  D. Levy,et al.  The effects of tobacco control policies on smoking rates: a tobacco control scorecard. , 2004, Journal of public health management and practice : JPHMP.

[52]  R B Williams,et al.  Characteristics of Socially Isolated Patients With Coronary Artery Disease Who Are at Elevated Risk for Mortality , 2001, Psychosomatic medicine.

[53]  C. Murray,et al.  On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. , 1999, Epidemiology.

[54]  Michael J. Zaleha,et al.  Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. , 2017, Lancet.

[55]  Un Desa Transforming our world : The 2030 Agenda for Sustainable Development , 2016 .

[56]  Allison H. Christian,et al.  Influence of Caregiving on Lifestyle and Psychosocial Risk Factors Among Family Members of Patients Hospitalized with Cardiovascular Disease , 2008, Journal of General Internal Medicine.

[57]  T. Holford Understanding the effects of age, period, and cohort on incidence and mortality rates. , 1991, Annual review of public health.